Thomas MacArthur sold Sanofi ADR (NASDAQ: SNY)
Thomas MacArthur (R-NJ), a U.S. Representative, has disclosed 1 trade in Sanofi ADR (SNY) since 2015, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Thomas MacArthur sold $15,001 - $50,000 of Sanofi ADR (NASDAQ: SNY) on January 27, 2015. Since that trade, SNY is up +56.46% against the S&P 500 up +334.48%, an outperformance of -278.02%.
Data updated
Thomas MacArthur's SNY trades vs the price
SNY is up +56.46% since Thomas MacArthur sold on January 27, 2015, versus +334.48% for the S&P 500.
Performance since this trade
All Thomas MacArthur SNY trades
Thomas MacArthur & SNY trading FAQ
Is it legal for Thomas MacArthur to trade Sanofi ADR (SNY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Sanofi ADR (SNY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Thomas MacArthur sell SNY?
Thomas MacArthur disclosed a sale of $15,001 - $50,000 of Sanofi ADR (SNY) on January 27, 2015, according to public STOCK Act filings.
How has SNY performed since Thomas MacArthur's trade?
Since Thomas MacArthur sold SNY on January 27, 2015, the stock is up +56.46%, versus +334.48% for the S&P 500 over the same period, an outperformance of -278.02%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SNY trades?
Quantellect tracks every disclosed congressional trade in Sanofi ADR (SNY) on the Sanofi ADR congressional trading page, which aggregates filings across all members of Congress.
Thomas MacArthur's SNY tradesAll congressional filings for Sanofi ADRThomas MacArthur's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.